Stephan Toutain - May 1, 2024 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Signature
/s/ Spencer Brown, Attorney-in-Fact
Stock symbol
PDSB
Transactions as of
May 1, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:17 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +200K $0.00 200K May 1, 2024 Common Stock 200K $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on May 1, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.